Markets
← Back to Stocks
WAT
WATERS CORP
Health Care · Life Sciences Tools & Services
$299.61
+1.53%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
BD spinoff integration concerns weigh on Waters despite strong Q4 beat
Waters fell 14.49% in pre-market to $326.04 on March 19 after reporting strong Q4 2025 adjusted EPS of $4.53 (beat $4.51) and revenue of $932M (beat $928M) on March 18. BD completed spinoff and combination of Biosciences business with Waters on February 9, 2026, creating integration concerns. Company projects 5.5-7% organic revenue growth and $14.30-$14.50 adjusted EPS for 2026.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$29.4B
P/E (TTM)27.8
Forward P/E18.3
Beta1.20
Div Yield—
Prev Close$295.09
RSI (14-Day)
38Neutral
0305070100
52-Week Range
$275.05$299.61$414.15
From High-27.7%
From Low+8.9%
Moving Averages
50d SMA
$346.14-13.4%
200d SMA
$339.74-11.8%
Price below 200d MA — bearish structure.
Returns
1W
+5.8%
1M
-8.5%
3M
-20.9%
6M
-1.3%
1Y
-21.6%
YTD
-21.6%
Volume
Today44K
20d Avg1.2M
Ratio0.04x